IN.TO - InMed Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 543.1M
Enterprise Value 324.48M
Trailing P/E N/A
Forward P/E 1-3.25
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.06
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.99

Trading Information

Stock Price History

Beta (3Y Monthly) 6.32
52-Week Change 3-64.38%
S&P500 52-Week Change 31.31%
52 Week High 31.0800
52 Week Low 30.2550
50-Day Moving Average 30.3063
200-Day Moving Average 30.4515

Share Statistics

Avg Vol (3 month) 3121.11k
Avg Vol (10 day) 3106.3k
Shares Outstanding 5134.29M
Float 168.06M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jul 31, 2019) 4179.15k
Short Ratio (Jul 31, 2019) 40.96
Short % of Float (Jul 31, 2019) 4N/A
Short % of Shares Outstanding (Jul 31, 2019) 40.06%
Shares Short (prior month Jun 28, 2019) 4123.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.24%
Return on Equity (ttm)-66.05%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.31M
Net Income Avi to Common (ttm)-12.01M
Diluted EPS (ttm)-0.0720
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.31M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)31.59
Book Value Per Share (mrq)0.13

Cash Flow Statement

Operating Cash Flow (ttm)-7.73M
Levered Free Cash Flow (ttm)-3.45M